Liver International
No correlation between MASLD and poor outcome of Atezolizumab-Bevacizumab therapy in patients with advanced HCC
Posted on
OUr founders
ISO 9001 Certified
OUr Institutionnal Supporters
Our network
Foundation for innovation
in Cardiometabolism and Nutrition
